Suppr超能文献

阿尔茨海默病神经影像学倡议在建立显性遗传性阿尔茨海默病网络中的作用。

The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer Network.

机构信息

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.

Knight Alzheimer Disease Research Center, Washington University School of Medicine, Saint Louis, Missouri, USA.

出版信息

Alzheimers Dement. 2024 Aug;20(8):5789-5791. doi: 10.1002/alz.14106. Epub 2024 Jul 3.

Abstract

The Dominantly Inherited Alzheimer Network (DIAN) initially was funded by the National Institute on Aging (NIA) in 2008 and thus was able to adopt and incorporate the protocols developed by the Alzheimer's Disease Neuroimaging Initiative (ADNI) that had been established by the NIA in 2004. The use of ADNI protocols for DIAN neuroimaging studies and assays of biological fluids for Alzheimer disease (AD) biomarkers permitted examination of the hypothesis that autosomal dominant AD (ADAD), studied by DIAN, and "sporadic" late-onset AD (LOAD), studied by ADNI, shared the same pathobiological construct. In a collaborative effort, the longitudinal DIAN and ADNI databases were compared and the findings supported the conclusion that ADAD and LOAD share a similar pathophysiology. The importance of the DIAN study thus is amplified by its relevance to LOAD, as characterized by the "parent" ADNI program.

摘要

家族性阿尔茨海默病网络(DIAN)最初于 2008 年由美国国家老龄化研究所(NIA)资助,因此能够采用并纳入由 NIA 于 2004 年建立的阿尔茨海默病神经影像学倡议(ADNI)制定的方案。为了对 DIAN 神经影像学研究和生物液体进行阿尔茨海默病(AD)生物标志物的检测,使用 ADNI 方案,对 DIAN 进行研究的常染色体显性遗传 AD(ADAD)和 ADNI 研究的“散发性”晚发性 AD(LOAD)进行了研究,它们具有相同的病理生物学结构。在一项合作努力中,对纵向 DIAN 和 ADNI 数据库进行了比较,研究结果支持了 ADAD 和 LOAD 具有相似病理生理学的结论。因此,由于与“母体”ADNI 计划的 LOAD 相关,DIAN 研究的重要性得到了放大。

相似文献

1
The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer Network.
Alzheimers Dement. 2024 Aug;20(8):5789-5791. doi: 10.1002/alz.14106. Epub 2024 Jul 3.
3
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
JAMA Neurol. 2023 Dec 1;80(12):1353-1363. doi: 10.1001/jamaneurol.2023.3618.
5
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.
Neurology. 2013 Jun 4;80(23):2130-7. doi: 10.1212/WNL.0b013e318295d6cf. Epub 2013 May 3.
6
Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?
Alzheimers Dement. 2019 Oct;15(10):1348-1356. doi: 10.1016/j.jalz.2019.07.010. Epub 2019 Sep 26.
10
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
Alzheimers Dement. 2015 Jul;11(7):730-3. doi: 10.1016/j.jalz.2015.05.007.

本文引用的文献

2
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4. doi: 10.1016/j.jalz.2014.07.003. Epub 2014 Oct 28.
3
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.
Clin Investig (Lond). 2012 Oct 1;2(10):975-984. doi: 10.4155/cli.12.93.
4
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101. doi: 10.1097/WAD.0b013e318191c7dd.
5
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6. doi: 10.1097/01.wad.0000213865.09806.92.
7
Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.
Arch Neurol. 2001 Sep;58(9):1395-402. doi: 10.1001/archneur.58.9.1395.
8
beta-peptide immunization: a possible new treatment for Alzheimer disease.
Arch Neurol. 2000 Jul;57(7):934-6. doi: 10.1001/archneur.57.7.934.
9
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.
Ann Neurol. 1999 Mar;45(3):358-68. doi: 10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验